vorinostat has been researched along with Leukemia, Prolymphocytic, T-Cell in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Leukemia, Prolymphocytic, T-Cell: A lymphoid leukemia characterized by a profound LYMPHOCYTOSIS with or without LYMPHADENOPATHY, hepatosplenomegaly, frequently rapid progression, and short survival. It was formerly called T-cell chronic lymphocytic leukemia.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Toutah, K | 1 |
Nawar, N | 1 |
Timonen, S | 1 |
Sorger, H | 1 |
Raouf, YS | 1 |
Bukhari, S | 1 |
von Jan, J | 1 |
Ianevski, A | 1 |
Gawel, JM | 1 |
Olaoye, OO | 1 |
Geletu, M | 1 |
Abdeldayem, A | 1 |
Israelian, J | 1 |
Radu, TB | 1 |
Sedighi, A | 1 |
Bhatti, MN | 1 |
Hassan, MM | 1 |
Manaswiyoungkul, P | 1 |
Shouksmith, AE | 1 |
Neubauer, HA | 1 |
de Araujo, ED | 1 |
Aittokallio, T | 1 |
Krämer, OH | 1 |
Moriggl, R | 1 |
Mustjoki, S | 1 |
Herling, M | 1 |
Gunning, PT | 1 |
1 other study available for vorinostat and Leukemia, Prolymphocytic, T-Cell
Article | Year |
---|---|
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bendamustine Hydrochloride; Bridged Bicyclo Compounds, He | 2021 |